Bausch & Lomb Corp

Bausch & Lomb has a global operating footprint with commercial presence in approximately 100 countries, so its revenue base is geographically diversified rather than concentrated in one market. The United States remains a major market, supported by a large commercial team and direct relationships with wholesalers, retailers, and eye-care practices. The company also relies on international commercial teams and distribution partners across Europe, Asia, Latin America, the Middle East, and Africa, which broadens reach but increases foreign-exchange and regulatory exposure. Because products are sold across many countries and channels, local reimbursement, pricing, and supply-chain conditions can affect performance differently by region. The company’s manufacturing and commercial network is global, which helps serve local demand but also creates exposure to cross-border logistics and compliance risks.

Bausch & Lomb faces a highly competitive eye-health market where product quality, efficacy, pricing, and promotion determine share, so new products from rivals can quickly pressure sales. Its business depends on manufacturing continuity and third-party supply chains, making it vulnerable to plant disruptions, single-source components, inventory swings, and distributor buying patterns. The company also has meaningful international exposure, so foreign exchange volatility, geopolitical disruption, and local regulatory changes can affect revenue and costs. Separation-related execution risk remains important because the company is still managing debt refinancing and the long-term implications of operating independently from Bausch Health. In addition, reimbursement pressure, product recalls, and litigation or indemnity obligations can affect both demand and profitability in a business that sells regulated medical and consumer eye-care products.